Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease

  • STATUS
    Recruiting
  • participants needed
    200
  • sponsor
    Jeil Pharmaceutical Co., Ltd.
Send
Updated on 16 February 2024
See if I qualify
endoscopy
esophagogastroduodenoscopy
esomeprazole
reflux
heartburn
acidity
esomeprazole 40 mg
acid reflux / gastroesophageal reflux

Summary

Clinical trial to evaluate the safety and efficacy of JP-1366 in patients with erosive gastroesophageal reflux disease

Details
Condition Gastroesophageal Reflux
Age 19years - 75years
Treatment JP-1366, JP-1366 placebo, Esomeprazole 40mg, Esomeprazole placebo
Clinical Study IdentifierNCT04282954
SponsorJeil Pharmaceutical Co., Ltd.
Last Modified on16 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Adults between 19 and 75 years old based on the date of written agreement
Those who have been diagnosed with erosive gastroesophageal reflux disease(EGRD) of LA Grade A-D on the upper gastrointestinal endoscopy
Those who experienced symptoms of heartburn or acid reflux within the last 7 days

Exclusion Criteria

Those who have undergone gastric acid suppression or gastric, esophageal surgery
Those who with clinically significant liver, kidney, nervous system, respiratory, endocrine, hematologic, cardiovascular, urinary system disease
Clinically significant abnormal laboratory values during screening
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

endoscopy
esophagogastroduodenoscopy
esomeprazole
reflux
heartburn
acidity
esomeprazole 40 mg
acid reflux / gastroesophageal reflux

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.